Plus500 Limited Passing away of Non-Executive Director (2714Y)
02 Enero 2024 - 1:00AM
UK Regulatory
TIDMPLUS
RNS Number : 2714Y
Plus500 Limited
02 January 2024
2 January 2024
Plus500 Ltd.
("Plus500", the "Company", or together with its subsidiaries the
"Group")
Passing away of Non-Executive Director
Plus500 announces with great sadness that Sigalia Heifetz,
Non-Executive Director, passed away on 30 December 2023. The Board
and colleagues from Plus500 would like to share their deepest
condolences with Sigalia's friends and family.
Jacob Frenkel, Chairman of the Board of Directors, commented:
"Everyone at Plus500 is deeply saddened at the passing of Sigalia
Heifetz. Our thoughts, sympathies and condolences are with her
family and friends during this difficult time. Sigalia joined the
Board of Plus500 about three years ago and her experience and
wisdom were a huge help to us all. The Board and I would like to
express our sincere appreciation for her significant
contribution."
For further details:
Plus500 Ltd.
Elad Even-Chen, Chief Financial +972 4 8189503
Officer +44 (0) 7551 654208
Owen Jones, Head of Investor ir@plus500.com
Relations
Dentons Global Advisors
James Melville-Ross +44 (0)20 7664 5095
James Styles plus500@dentonsglobaladvisors.com
Methuselah Tanyanyiwa
About Plus500
Plus500 is an established global multi-asset fintech group
operating proprietary technology-based trading platforms. Plus500
offers customers a range of trading products, including OTC
("Over-the-Counter" products, namely Contracts for Difference
(CFDs)), share dealing, as well as futures and options on
futures.
The Group retains operating licences and is regulated in the
United Kingdom, Australia, Cyprus, Israel, New Zealand, South
Africa, Singapore, the Seychelles, the United States, Estonia,
Japan, the UAE and the Bahamas and through its OTC product
portfolio, offers more than 2,500 different underlying global
financial instruments, comprising equities, indices, commodities,
options, ETFs, foreign exchange and cryptocurrencies. Customers of
the Group can trade its OTC products in more than 50 countries and
in 30 languages.
Plus500's trading platforms are accessible from multiple
operating systems (Windows, iOS and Android) and web browsers.
Customer care is and has always been integral to Plus500, as such,
OTC customers cannot be subject to negative balances. A free demo
account is available on an unlimited basis for OTC trading platform
users and sophisticated risk management tools are provided free of
charge to manage leveraged exposure and stop losses to help
customers protect profits, while limiting capital losses.
Plus500 shares have a premium listing on the Main Market of the
London Stock Exchange (symbol: PLUS) and are a constituent of the
FTSE 250 index. www.plus500.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOABBMRTMTMMBAI
(END) Dow Jones Newswires
January 02, 2024 02:00 ET (07:00 GMT)
Plus500 (AQSE:PLUS.GB)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Plus500 (AQSE:PLUS.GB)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024